← FDA DRUG APPROVALS

FDA ANDA · ANDA075437

CROMOLYN SODIUM

Sponsor: FERA PHARMS LLC

APPLICATION
ANDA075437
TYPE
ANDA
ORIGINAL APPROVAL
2000-04-21
LATEST ACTION
2022-08-10
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

CROMOLYN SODIUMPrescription
CROMOLYN SODIUM 10MG/ML · SOLUTION · INHALATION

Approval history

2022-08-10Manufacturing (CMC) · Supplement 1 · unknownAP
2000-04-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →